The global clinical trial supplies market is projected to reach USD 5.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 9.7% during the forecast period of 2022 to 2027. The growing number of registered trials that are conducted globally and increasing R&D expenditure in pharmaceutical and biotechnology companies are driving the market. However, the huge cost of drug development and clinical trials is a threat in the growth of this market during the forecast period.
The global clinical trial supplies market is competitive. Prominent players operating in the global clinical trial supplies market include Thermo Fisher Scientific, Inc. (US), Marken (US), Catalent, Inc. (US), Eurofins Scientific (France), PRA Health Sciences (US), Parexel International Corporation. (US), Biocair (UK), Almac Group (UK), Piramal Pharma Solutions (India), Infosys (India), PCI Pharma Services (US), Liveo Research (Switzerland), Capsugel (Switzerland). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product approvals to expand their manufacturing capabilities and increase market presence.
To know about the assumptions considered for the study download the pdf brochure
THERMO FISHER SCIENTIFIC
Thermo Fisher Scientific (US) is a prominent player operating in the clinical trial supplies market. The company has a strong geographic footprint serving over 400,000 customers in pharmaceutical and biotech companies. Thermo Fisher also has an extensive distribution channel across the globe. The firm clocked more than USD 14.9 billion in revenue in 2021 from its Laboratory Products and Services segment, which provides clinical trial supplies. The company acquired PPD to support its clinical supply offerings. The company is moving towards decentralizing its service offerings to expand its geographic footprint.
Marken is a wholly owned subsidiary of UPS, a global leader in logistics and distribution. United Parcel Service (UPS) is a supply chain management company that provides package delivery services. Marken offers its services across the following segments—Biological Shipments, Vaccines, Patient Care, Clinical Storage and Distribution, Management and Oversight, Technology, Packaging, and Service Levels. It provides clinical drug supply services under its Clinical Storage and Distribution segment
Catalent (US) is one of the leading providers of clinical trial supplies. It mainly focuses on business strategies such as service launches, expansions, acquisitions, and partnerships. In 2021, Catalent expanded and added cryogenic capabilities at its Philadelphia clinical supply services facility. In 2021, Catalent partnered with Stirling Ultracold to enhance its cold chain capabilities. In 2020, Catalent launched FlexDirect, a new direct-to-patient service for clinical trials, to give its clients options to customize their supplies procurement as per their requirements. In 2019, Catalent launched CTSuccess, which enhanced the company’s clinical trial planning services. Catalent also focuses on expanding its facilities worldwide, thereby strengthening its geographical footprint in the clinical trial supplies market. Catalent operates in countries across North America, Europe, Asia Pacific, and Latin America. It has a strong presence in China, Japan, Italy, the UK, France, Belgium, Germany, Argentina, Brazil, Uruguay, the US, and Canada.
Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases (I to IV), Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs) - Global Forecast 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE